Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biogen prices new, long-acting hemophilia med with eye on patient-switching
Fierce Pharma Marketing
Wednesday, July 9, 2014 - 5:15pm
tags:
Biogen Idec, hemophilia, patient-switching, Alprolix
Sanofi-Regeneron drug tames eczema in study
Yahoo/Reuters
Wednesday, July 9, 2014 - 5:09pm
tags:
Sanofi, Regeneron, eczema, atopic dermatitis, dupilumab
Salix Pharmaceuticals: ‘Better Deal Than It Is Being Viewed’
Barron's
Wednesday, July 9, 2014 - 4:59pm
tags:
Salix, Cosmo Pharma, M&A
Lung Cancer Genomic Mapping Yields New Targets in Study
Bloomberg
Wednesday, July 9, 2014 - 4:55pm
tags:
genomic mapping, lung cancer, Pfizer, Xalkori
GlaxoSmithKline: Fortifying Its Position In The Respiratory Segment
Seeking Alpha
Wednesday, July 9, 2014 - 3:08pm
tags:
GSK, asthma, Breo Ellipta
Judge tosses decade-old investor suit against Pfizer and Celebrex weeks before trial
Fierce Pharma
Wednesday, July 9, 2014 - 11:51am
tags:
Pfizer, Celebrex
Concert Pharmaceuticals' Shares Slip Despite Favorable FDA Meeting
Yahoo/Zacks.com
Wednesday, July 9, 2014 - 11:50am
tags:
Concert Pharmaceuticals, FDA, CTP-499, diabetic nephropathy
Actavis cans 190 Forest workers while 6 execs share up to $186M in deal 'awards'
Fierce Pharma
Wednesday, July 9, 2014 - 10:58am
tags:
Forest Labs, Actavis, layoffs
How Will Allergan (AGN) Stock React To New Restructuring Plan?
TheStreet.com
Wednesday, July 9, 2014 - 9:43am
tags:
Allergan, restructuring, Valeant Pharmaceuticals
Biotech Stock Roundup: Regado Plunges on Study Update, Jazz Gains on Product Acquisition Deal
Yahoo/Zacks.com
Wednesday, July 9, 2014 - 9:26am
tags:
Regado Biosciences, Jazz Pharmaceuticals, Regeneron, Sanofi, blinatumomab, Amgen, Defitelio
Celgene spondylitis drug misses main goal in late-stage study
Yahoo/Reuters
Wednesday, July 9, 2014 - 8:28am
tags:
Celgene, ankylosing spondylitis, Otezla
Allergan Said to Plan Cost Cuts Amid Valeant Defense
Bloomberg
Wednesday, July 9, 2014 - 8:11am
tags:
Allergan, Valeant Pharmaceuticals, restructuring, M&A
Salix to Merge With Cosmo in Latest Tax Inversion Deal
Bloomberg
Wednesday, July 9, 2014 - 8:03am
tags:
Salix, Cosmo Pharma, M&A, taxes
AbbVie forced to retract comments in Shire takeover fight
Yahoo/Reuters
Wednesday, July 9, 2014 - 7:47am
tags:
M&A, Shire, AbbVie
Servier to Teva Fined $582.2 Million on Generic Delays
Bloomberg
Wednesday, July 9, 2014 - 7:47am
tags:
Servier, Teva Pharmaceutical, generics, perindopril
Pfizer wins dismissal of U.S. investor class action ahead of trial
Yahoo/Reuters
Wednesday, July 9, 2014 - 7:46am
tags:
Pfizer, investors
If AbbVie Wants Shire’s Low Tax Rate, Price May Go Up
Bloomberg
Wednesday, July 9, 2014 - 7:45am
tags:
Shire, AbbVie, M&A
GlaxoSmithKline Is Moving Forward After Woeful Performance
Seeking Alpha
Tuesday, July 8, 2014 - 5:40pm
tags:
GSK, vaccines, oncology, Novartis, Anoro Ellipta
Study Shows No Link Between Gardasil And Blood Clots
Forbes
Tuesday, July 8, 2014 - 5:07pm
tags:
Gardasil, Merck, HPV, vaccines, blood clots
Otonomy heads to the FDA after its ear treatment clears Phase III
Fierce Biotech
Tuesday, July 8, 2014 - 4:59pm
tags:
Otonomy, FDA, AuriPro, OTO-201, ear tubes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.